Astria Therapeutics (ATXS) Change in Account Payables: 2013-2024
Historic Change in Account Payables for Astria Therapeutics (ATXS) over the last 12 years, with Dec 2024 value amounting to $2.8 million.
- Astria Therapeutics' Change in Account Payables fell 330.15% to -$893,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$211,000, marking a year-over-year decrease of 131.87%. This contributed to the annual value of $2.8 million for FY2024, which is 287.17% up from last year.
- Latest data reveals that Astria Therapeutics reported Change in Account Payables of $2.8 million as of FY2024, which was up 287.17% from $725,000 recorded in FY2023.
- In the past 5 years, Astria Therapeutics' Change in Account Payables registered a high of $2.8 million during FY2024, and its lowest value of -$2.0 million during FY2021.
- In the last 3 years, Astria Therapeutics' Change in Account Payables had a median value of $725,000 in 2023 and averaged $922,000.
- Its Change in Account Payables has fluctuated over the past 5 years, first plummeted by 666.28% in 2021, then surged by 287.17% in 2024.
- Astria Therapeutics' Change in Account Payables (Yearly) stood at $347,000 in 2020, then crashed by 666.28% to -$2.0 million in 2021, then surged by 61.02% to -$766,000 in 2022, then soared by 194.65% to $725,000 in 2023, then skyrocketed by 287.17% to $2.8 million in 2024.